Versant Venture Capital VII, L.P.

Track

Insider profile

Versant Venture Capital VII, L.P.'s trades of Aduro Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
294.46
Quantity 79,293 -43.0%
Value US$4,109,135
Transaction date
Planned sale
Price
160.44
Quantity 11,031 +0.7%
Value US$848,888
Transaction date
Planned sale
Price
15.83
Quantity 58,857 -14.8%
Value US$821,256
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-05 2022-01-03
PlS Planned sale
79,293 -43.0%
294.46
US$4,109,135 		79,293 -43.0% 294.46 US$4,109,135
2022-01-05 2022-01-03
PlS Planned sale
11,031 +0.7%
160.44
US$848,888 		11,031 +0.7% 160.44 US$848,888
2022-01-05 2022-01-03
PlS Planned sale
58,857 -14.8%
15.83
US$821,256 		58,857 -14.8% 15.83 US$821,256